These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8757016)

  • 1. Predictors of mortality in patients diagnosed with probable Alzheimer's disease.
    Bowen JD; Malter AD; Sheppard L; Kukull WA; McCormick WC; Teri L; Larson EB
    Neurology; 1996 Aug; 47(2):433-9. PubMed ID: 8757016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study.
    Reisberg B; Ferris SH; Franssen EH; Shulman E; Monteiro I; Sclan SG; Steinberg G; Kluger A; Torossian C; de Leon MJ; Laska E
    Int Psychogeriatr; 1996; 8(2):291-311. PubMed ID: 8994898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of possible versus probable Alzheimer's disease.
    Villareal DT; Grant E; Miller JP; Storandt M; McKeel DW; Morris JC
    Neurology; 2003 Sep; 61(5):661-7. PubMed ID: 12963758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after initial diagnosis of Alzheimer disease.
    Larson EB; Shadlen MF; Wang L; McCormick WC; Bowen JD; Teri L; Kukull WA
    Ann Intern Med; 2004 Apr; 140(7):501-9. PubMed ID: 15068977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal signs in patients with probable Alzheimer disease.
    Lopez OL; Wisnieski SR; Becker JT; Boller F; DeKosky ST
    Arch Neurol; 1997 Aug; 54(8):969-75. PubMed ID: 9267971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study.
    Geerlings MI; Deeg DJ; Schmand B; Lindeboom J; Jonker C
    Neurology; 1997 Sep; 49(3):798-802. PubMed ID: 9305343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
    Suh GH; Kil Yeon B; Shah A; Lee JY
    Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.
    Morris JC; Edland S; Clark C; Galasko D; Koss E; Mohs R; van Belle G; Fillenbaum G; Heyman A
    Neurology; 1993 Dec; 43(12):2457-65. PubMed ID: 8255439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.
    Small BJ; Viitanen M; Bäckman L
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M299-304. PubMed ID: 9310084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease.
    Heyman A; Peterson B; Fillenbaum G; Pieper C
    Neurology; 1996 Mar; 46(3):656-60. PubMed ID: 8618662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry.
    Garcia-Ptacek S; Farahmand B; Kåreholt I; Religa D; Cuadrado ML; Eriksdotter M
    J Alzheimers Dis; 2014; 41(2):467-77. PubMed ID: 24625796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
    Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
    J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California.
    Moritz DJ; Fox PJ; Luscombe FA; Kraemer HC
    Arch Neurol; 1997 Jul; 54(7):878-85. PubMed ID: 9236577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group.
    Gambassi G; Lapane KL; Landi F; Sgadari A; Mor V; Bernabie R
    Neurology; 1999 Aug; 53(3):508-16. PubMed ID: 10449112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality in patients with Alzheimer's disease living in nursing homes.
    Gambassi G; Landi F; Lapane KL; Sgadari A; Mor V; Bernabei R
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):59-65. PubMed ID: 10369823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease.
    Bruandet A; Richard F; Bombois S; Maurage CA; Deramecourt V; Lebert F; Amouyel P; Pasquier F
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):133-9. PubMed ID: 18977819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.
    Lopez OL; Brenner RP; Becker JT; Ulrich RF; Boller F; DeKosky ST
    Neurology; 1997 Jun; 48(6):1521-5. PubMed ID: 9191759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.